Even though transcriptomic changes do not always reflect changes in the proteome these encouraging results led us to hypothesize that activation of the P2RX7/IL-18 axis may restrain lung fibrosis progression by promoting an antifibrotic immune microenvironment. Here, IL18 is linked to pulmonary fibrosis.